Ex parte HASELTINE et al. - Page 2




              Appeal No. 95-2208                                                                                         
              Application 07/987,572                                                                                     



                                               DECISION ON APPEAL                                                        
                     This is an appeal under 35 U.S.C. §  134 from the final rejection of claims                         
              1 through 11.  Subsequent to the final rejection, appellants canceled claims 3, 4, and                     
              7 and added claims 15 through 17.  Thus, claims 1, 2, 5, 6, 8 through 11 and 15 through 17                 
              are before us for consideration.  Claims 12 through 14 are pending, but have been                          
              withdrawn from consideration by the examiner.                                                              
                     Claims 1 and 2 are illustrative of the subject matter on appeal and read as follows:                
                     1.   A vector comprising:                                                                           
                     (a)  a sufficient number of nucleotides corresponding to an HIV genome to express                   
              HIV gene products necessary for viral replication and infectivity (the HIV segment); and                   
              inserted in the HIV segment (I) in a region of non-essential HIV nucleotide sequences or (ii)              
              instead of a region of non-essential HIV nucleotide sequences                                              
                     (b)  a sufficient number of nucleotides corresponding to a heterologous gene to                     
              express a functional protein (the heterologous gene segment).                                              
                     2.   The vector of claim 1, wherein the heterologous gene segment corresponds to a                  
              marker gene.                                                                                               
                     The examiner states at page 4 of the examiner's answer (Paper No. 22, August 15,                    
                                                                                                          2              
              1994) that prior art is not relied upon in support of the rejection of the claims on appeal.               

                     The examiner lists four documents at page 5 of the examiner's answer, stating that the2                                                                                                  
              references are “relied upon for support of the arguments presented here and below.”  As stated in In re    
              Hoch, 428 F.2d 1341, 1342 n.3, 166 USPQ 406, 407 n.3 (CCPA 1970) “[w]here a reference is relied on to      
              support a rejection, whether or not in a 'minor capacity,' there would appear to be no excuse for not      
              positively including the reference in the statement of the rejection.”  Since the examiner has stated that he
              does not rely upon prior art in support of the rejection of record, we have not considered the four references
                                                                                               (continued...)            
                                                            2                                                            





Page:  Previous  1  2  3  4  5  6  Next 

Last modified: November 3, 2007